
1. n engl j med. 1997 may 22;336(21):1487-93.

thalidomide treatment oral aphthous ulcers patients human
immunodeficiency virus infection. national institute allergy infectious
diseases aids clinical trials group.

jacobson jm(1), greenspan js, spritzler j, ketter n, fahey jl, jackson jb, fox l,
chernoff m, wu aw, macphail la, vasquez gj, wohl da.

author information: 
(1)department medicine, bronx veterans affairs medical center mount sinai 
school medicine, ny 10468, usa.

comment in
    n engl j med. 1997 oct 9;337(15):1086-7.

background: patients advanced human immunodeficiency virus (hiv)
infection, aphthous ulceration mouth oropharynx become extensive
and debilitating. preliminary reports suggest thalidomide may promote the
healing oral aphthous ulcers.
methods: performed double-blind, randomized, placebo-controlled study of
thalidomide therapy oral aphthous ulcers hiv-infected patients. the
patients received four-week course either 200 mg thalidomide placebo
orally per day. evaluated weekly condition ulcers, 
their quality life, evidence toxicity. assays performed plasma
tumor necrosis factor alpha (tnf-alpha), soluble tnf-alpha receptors, hiv
rna.
results: sixteen 29 patients thalidomide group (55 percent) had
complete healing aphthous ulcers four weeks, compared only
2 28 patients placebo group (7 percent; odds ratio, 15; 95 percent
confidence interval adjustment group sequential testing, 1.8 499;
unadjusted p<0.001). pain diminished ability eat improved thalidomide
treatment. adverse effects noted thalidomide included somnolence and
rash (7 patients each), 6 29 patients discontinued treatment because
of toxicity. thalidomide treatment increased hiv rna levels (median increase,
0.42 log10 copies per milliliter; increase placebo, 0.05; p=0.04). with
thalidomide treatment unexpected increases plasma
concentrations tnf-alpha soluble tnf-alpha receptors.
conclusions: thalidomide effective treatment aphthous ulceration the
mouth oropharynx patients hiv infection.

doi: 10.1056/nejm199705223362103 
pmid: 9154767  [indexed medline]

